Exelixis (EXEL) Treasury Shares (2010 - 2026)
Exelixis' (EXEL) quarterly Treasury Shares came in at $18.2 million in Q2 2026, down 19.47% year-on-year from $22.6 million in Q2 2025, and up 5.93% quarter-over-quarter from $17.2 million in Q1 2026.
Exelixis (EXEL) Treasury Shares (2010 - 2026) Analysis & Trends
Exelixis' Treasury Shares history runs 17 years deep, the most recent figure standing at $18.2 million for Q2 2026.
- On a quarterly basis, Treasury Shares fell 19.47% year-over-year to $18.2 million in Q2 2026; TTM through Apr 2026 was $18.2 million, a 19.47% decrease from a year earlier, with the FY2026 full-year figure at $17.2 million, up 3726.5% from the prior year.
- Treasury Shares improved to $18.2 million in Q2 2026 per EXEL's latest filing, from $17.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $22.6 million in Q2 2025 and bottomed at $449000.0 in Q1 2025.
- The 5-year median for Treasury Shares is $11.3 million (2023), against an average of $10.2 million.
- Across the five-year window, Treasury Shares surged 6973.54% in 2022 and sank 96.22% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $11.3 million in 2022, then grew by 5.14% to $11.9 million in 2023, then sank by 93.26% to $800000.0 in 2024, then jumped by 2350.0% to $19.6 million in 2025, then decreased by 7.14% to $18.2 million in 2026.
- Per Business Quant, the three latest EXEL Treasury Shares figures stand at $18.2 million (Q2 2026), $17.2 million (Q1 2026), and $19.6 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 18.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 18.20 Mn |
| Apr 3, 2026 | 18.20 Mn |
| Jan 2, 2026 | 17.18 Mn |
| Jan 2, 2026 | 17.18 Mn |
| Oct 3, 2025 | 19.60 Mn |
| Oct 3, 2025 | 19.60 Mn |
| Jul 4, 2025 | 20.50 Mn |
| Jul 4, 2025 | 20.50 Mn |
| Apr 4, 2025 | 22.60 Mn |
| Apr 4, 2025 | 22.60 Mn |
| Jan 3, 2025 | 449,000.00 |
| Jan 3, 2025 | 449,000.00 |
| Sep 27, 2024 | 800,000.00 |
| Sep 27, 2024 | 800,000.00 |
| Jun 28, 2024 | 900,000.00 |
| Jun 28, 2024 | 900,000.00 |
| Mar 29, 2024 | 900,000.00 |
| Mar 29, 2024 | 900,000.00 |
| Dec 29, 2023 | 11.87 Mn |
| Dec 29, 2023 | 11.87 Mn |